Novavax scores $1.6B contract for coronavirus vaccine, shifts flu strategy as capacity is ‘absorbed by Covid’
The contract represents a major bet on the Gaithersburg biotech ’s coronavirus work as the country hustles to find a viable vaccine to help end the pandemic.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Sara Gilgore Source Type: news
More News: Biotechnology | Contracts | Coronavirus | COVID-19 | Health Management | Pandemics | Vaccines